Adirondack Trust Company’s Guardant Health GH Stock Holding History

Adirondack Trust Company’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3K	Hold	115	–	–	0.01%	367
2026 Q1	$10.6K	Hold	115	–	–	﹤0.01%	387
2025 Q4	$11.7K	Hold	115	–	–	﹤0.01%	374
2025 Q3	$7.18K	Hold	115	–	–	﹤0.01%	420
2025 Q2	$5.98K	Hold	115	–	–	﹤0.01%	397
2025 Q1	$4.9K	Hold	115	–	–	﹤0.01%	403
2024 Q4	$3.51K	Hold	115	–	–	﹤0.01%	427
2024 Q3	$2.64K	Hold	115	–	–	﹤0.01%	444
2024 Q2	$3.32K	Hold	115	–	–	﹤0.01%	432
2024 Q1	$2.37K	Hold	115	–	–	﹤0.01%	462
2023 Q4	$2.19K	Hold	115	–	–	﹤0.01%	459
2023 Q3	$3.41K	Hold	115	–	–	﹤0.01%	432
2023 Q2	$4.49K	Hold	115	–	–	﹤0.01%	401
2023 Q1	$2.69K	Hold	115	–	–	﹤0.01%	435
2022 Q4	$3.13K	Hold	115	–	–	﹤0.01%	421
2022 Q3	$6K	Hold	115	–	–	﹤0.01%	371
2022 Q2	$5K	Hold	115	–	–	﹤0.01%	382
2022 Q1	$8K	Hold	115	–	–	﹤0.01%	344
2021 Q4	$12K	Hold	115	–	–	0.01%	287
2021 Q3	$13K	Hold	115	–	–	0.01%	289
2021 Q2	$14K	Hold	115	–	–	0.01%	277
2021 Q1	$18K	Hold	115	–	–	0.01%	253
2020 Q4	$18K	Hold	115	–	–	0.01%	245
2020 Q3	$13K	Hold	115	–	–	0.01%	227
2020 Q2	$10K	Hold	115	–	–	0.01%	247
2020 Q1	$8K	Hold	115	–	–	0.01%	248
2019 Q4	$9K	Hold	115	–	–	0.01%	261
2019 Q3	$7K	Hold	115	–	–	﹤0.01%	271
2019 Q2	$10K	Hold	115	–	–	0.01%	261
2019 Q1	$8K	Buy	+115	New	+$6.38K	0.01%	262

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Adirondack Trust Company's GH Position: Q2 2026 in Review

Adirondack Trust Company held its Guardant Health (GH) position steady in Q2 2026 at 115 shares worth $17.3K. The position accounts for 0.01% of the portfolio, ranked #367.

Adirondack Trust Company first reported a position in GH in Q1 2019 and has held it in 30 quarters since. The position peaked at $18K in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Adirondack Trust Company held 115 shares of Guardant Health worth $17.3K as of Q2 2026.
Adirondack Trust Company left its Guardant Health share count unchanged in Q2 2026.
Guardant Health made up 0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #367 holding.
Adirondack Trust Company first reported a position in Guardant Health in Q1 2019 and has held it in 30 quarters since.
Adirondack Trust Company's Guardant Health position peaked at $18K in Q1 2021.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.